Celon Pharma Dividends and Buybacks
Dividend criteria checks 0/6
Celon Pharma is a dividend paying company with a current yield of 0.3%.
Key information
0.3%
Dividend yield
-2.8%
Buyback Yield
| Total Shareholder Yield | -2.5% |
| Future Dividend Yield | 1.2% |
| Dividend Growth | 2.8% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | €0.080 |
| Payout ratio | 23% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 8RP is not paying a notable dividend for the German market, therefore no need to check if payments are stable.
Growing Dividend: 8RP is not paying a notable dividend for the German market, therefore no need to check if payments are increasing.
Dividend Yield vs Market
| Celon Pharma Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (8RP) | 0.3% |
| Market Bottom 25% (DE) | 1.7% |
| Market Top 25% (DE) | 4.8% |
| Industry Average (Pharmaceuticals) | 1.4% |
| Analyst forecast (8RP) (up to 3 years) | 1.2% |
Notable Dividend: 8RP's dividend (0.3%) isn’t notable compared to the bottom 25% of dividend payers in the German market (1.76%).
High Dividend: 8RP's dividend (0.3%) is low compared to the top 25% of dividend payers in the German market (4.76%).
Earnings Payout to Shareholders
Earnings Coverage: 8RP is not paying a notable dividend for the German market.
Cash Payout to Shareholders
Cash Flow Coverage: 8RP is paying a dividend but the company has no free cash flows.